PAVM Earnings PAVmed Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -4.42 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -5.63 | 2026-03-27 | 10-K |
| Q3 2025 | 2025-09-30 | -0.11 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | 0.13 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | 10.10 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | 14.90 | 2026-03-27 | 10-K |
| Q3 2025 | 2024-09-30 | 0.79 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -3.78 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -2.62 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -9.16 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -7.23 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -4.86 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -2.78 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -15.03 | 2024-03-25 | 10-K |
| Q3 2023 | 2022-09-30 | -0.78 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.49 | 2023-08-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.